675 related articles for article (PubMed ID: 30169897)
1. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
[TBL] [Abstract][Full Text] [Related]
2. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
[TBL] [Abstract][Full Text] [Related]
3. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
4. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
[TBL] [Abstract][Full Text] [Related]
5. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
[TBL] [Abstract][Full Text] [Related]
6. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
[TBL] [Abstract][Full Text] [Related]
7. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
Carvalho de Abreu DC; Pieruccini-Faria F; Sarquis-Adamson Y; Black A; Fraser J; Van Ooteghem K; Cornish B; Grimes D; Jog M; Masellis M; Steeves T; Nanayakkara N; Ramirez J; Scott C; Holmes M; Ozzoude M; Berezuk C; Symons S; Mohammad Hassan Haddad S; Arnott SR; Binns M; Strother S; Beaton D; Sunderland K; Theyers A; Tan B; Zamyadi M; Levine B; Orange JB; Roberts AC; Lou W; Sujanthan S; Breen DP; Marras C; Kwan D; Adamo S; Peltsch A; Troyer AK; Black SE; McLaughlin PM; Lang AE; McIlroy W; Bartha R; ; Montero-Odasso M
Eur J Neurol; 2023 Apr; 30(4):920-933. PubMed ID: 36692250
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.
Dadar M; Zeighami Y; Yau Y; Fereshtehnejad SM; Maranzano J; Postuma RB; Dagher A; Collins DL
Neuroimage Clin; 2018; 20():892-900. PubMed ID: 30292088
[TBL] [Abstract][Full Text] [Related]
9. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
[TBL] [Abstract][Full Text] [Related]
10. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
[TBL] [Abstract][Full Text] [Related]
11. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
Chen HM; Zhang MM; Wang YL
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(43):3397-3401. PubMed ID: 33238668
[No Abstract] [Full Text] [Related]
12. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.
Dadar M; Gee M; Shuaib A; Duchesne S; Camicioli R
Neuroimage Clin; 2020; 27():102353. PubMed ID: 32745994
[TBL] [Abstract][Full Text] [Related]
13. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
[TBL] [Abstract][Full Text] [Related]
14. Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's disease.
Huang X; Wen MC; Ng SY; Hartono S; Chia NS; Choi X; Tay KY; Au WL; Chan LL; Tan EK; Tan LC
Eur J Neurol; 2020 Jun; 27(6):959-966. PubMed ID: 32124496
[TBL] [Abstract][Full Text] [Related]
15. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC
Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194
[TBL] [Abstract][Full Text] [Related]
16. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
[TBL] [Abstract][Full Text] [Related]
17. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
[TBL] [Abstract][Full Text] [Related]
18. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.
González-Redondo R; Toledo J; Clavero P; Lamet I; García-García D; García-Eulate R; Martínez-Lage P; Rodríguez-Oroz MC
Eur J Neurol; 2012 Aug; 19(8):1100-7. PubMed ID: 22360775
[TBL] [Abstract][Full Text] [Related]
19. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
20. Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson's Disease.
Lee YH; Lee WJ; Chung SJ; Yoo HS; Jung JH; Baik K; Sohn YH; Seong JK; Lee PH
J Parkinsons Dis; 2021; 11(1):239-249. PubMed ID: 33074193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
